MIMETAS
Company Snapshot
Founded: 2013
Entity Type: Private
Employees: 80
Region: The Netherlands
Headquarter: Oegstgeest, The Netherlands
Key Geographics: The Netherlands, U.S., Japan
Corporate Address: Biopartner Building 5, De Limes 7, 2342 DH Oegstgeest The Netherlands Tel. +31-0-85-888-31-61 www.mimetas.com
Company Overview
Mimetas is involved in developing novel hardware, disease models, and screenable assays. The company offers its products to pharmaceutical and academic research institutions. The company also provides custom tissue models to advance screening and the development of personalized therapies. Mimetas developed the OrganoPlate platform to develop disease and toxicology models for R&D and drug screening. The various models offered by the company include brain, kidney toxicity, liver, cancer, gut, and endothelial vasculature. The vasculature models can be integrated with other tissue cultures to create vascularized tissue models. In 2018, the company opened a subsidiary in Tokyo to broaden its presence in Asia.
MIMETAS In News
Company's Business Segments
- Products : The company generates revenue through products such as OrganoReady, Instruments, Workshops and Trainings, OrganoStart Packages.
Applications/End User Industries
- Healthcare
- Pharmaceuticals
- Life Sciences